Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.60
3.95 (0.43%)
< Home < Back

Natco Pharma - Quaterly Results

Date: 09-08-2023
The sales moved up 30.11% to Rs. 10483.00 millions for the June 2023 quarter as compared to Rs. 8057.00 millions during the year-ago period.Good  Net Profit growth of 31.59% reported above the corresponding previous quarter figure of Rs. 3080.00 millions to Rs. 4053.00 millioins.Operating profit for the quarter ended June 2023 rose to 5183.00 millions as compared to 4126.00 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 10483.00 8057.00 30.11 10483.00 8057.00 30.11 23510.00 17678.00 32.99
Other Income 146.00 332.00 -56.02 146.00 332.00 -56.02 855.00 946.00 -9.62
PBIDT 5183.00 4126.00 25.62 5183.00 4126.00 25.62 9302.00 3076.00 202.41
Interest 32.00 27.00 18.52 32.00 27.00 18.52 86.00 133.00 -35.34
PBDT 5151.00 4099.00 25.66 5151.00 4099.00 25.66 9216.00 2943.00 213.15
Depreciation 399.00 369.00 8.13 399.00 369.00 8.13 1509.00 1384.00 9.03
PBT 4752.00 3730.00 27.40 4752.00 3730.00 27.40 7707.00 1559.00 394.36
TAX 699.00 650.00 7.54 699.00 650.00 7.54 1336.00 168.00 695.24
Deferred Tax -139.00 -10.00 1290.00 -139.00 -10.00 1290.00 5.00 -157.00 -103.18
PAT 4053.00 3080.00 31.59 4053.00 3080.00 31.59 6371.00 1391.00 358.02
Equity 358.00 365.00 -1.92 358.00 365.00 -1.92 365.00 365.00 0.00
PBIDTM(%) 49.44 51.21 -3.45 49.44 51.21 -3.45 39.57 17.40 127.39